Skip to main content
. 2023 Mar 3;3(2):230–235. doi: 10.21873/cdp.10206

Table I. Patient distribution in analyzed parameters (n=75).

graphic file with name cdp-3-231-i0001.jpg

PS: Performance status; HB: hemoglobin; TFPC: time from prior chemotherapy; NLR: neutrophil-to-lymphocyte ratio; SD: standard deviation; PLR: platelet-to-lymphocyte ratio.